HIF1A and head and neck squamous cell carcinoma: Similarly, Wu et al. reported that in head and neck squamous cell carcinoma, hypoxia enhances ROS release and promotes mitochondrial fission factor (Mff) expression and chemical sensitivity to cisplatin via hypoxia inducible factor 1 alpha (HIF1α)/Mff regulation (Wu et al., 2021).